IRIS
PIETRA, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.339
Totale 1.339
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.339
Totale 1.339
Salva come PNG Salva come JPEG
Città #
Genova 897
Rapallo 282
Genoa 142
Bordighera 18
Totale 1.339
Salva come PNG Salva come JPEG
Nome #
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function, file e268c4c5-f6cb-a6b7-e053-3a05fe0adea1 160
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines, file e268c4ca-6b99-a6b7-e053-3a05fe0adea1 137
Hypoxia modifies the transcriptome of human NK cells, modulates their immunoregulatory profile, and influences NK cell subset migration, file e268c4ca-3200-a6b7-e053-3a05fe0adea1 128
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation, file e268c4ca-69f5-a6b7-e053-3a05fe0adea1 126
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?, file e268c4ca-3a58-a6b7-e053-3a05fe0adea1 116
Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts, file e268c4ca-638d-a6b7-e053-3a05fe0adea1 98
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function, file e268c4ca-638a-a6b7-e053-3a05fe0adea1 91
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition, file e268c4ca-1f5f-a6b7-e053-3a05fe0adea1 78
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab, file e268c4ca-5ff0-a6b7-e053-3a05fe0adea1 78
L19-IL2 immunocytokine in combination with the anti-syndecan-1 46F2SIP antibody format: A new targeted treatment approach in an ovarian carcinoma model, file e268c4cc-8ffd-a6b7-e053-3a05fe0adea1 78
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28, file e268c4cc-ff06-a6b7-e053-3a05fe0adea1 74
Exploiting Human NK Cells in Tumor Therapy, file e268c4cd-1e49-a6b7-e053-3a05fe0adea1 65
A conserved energetic footprint underpins recognition of Human Leukocyte Antigen-E by two distinct αβ T cell receptors, file e268c4ca-1d87-a6b7-e053-3a05fe0adea1 60
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer, file e268c4cc-def9-a6b7-e053-3a05fe0adea1 8
NK cells and ILCs in tumor immunotherapy, file e268c4cd-065d-a6b7-e053-3a05fe0adea1 5
Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board, file e268c4ca-75d0-a6b7-e053-3a05fe0adea1 4
L19-IL2 immunocytokine in combination with the anti-syndecan-1 46F2SIP antibody format: A new targeted treatment approach in an ovarian carcinoma model, file e268c4cb-37d3-a6b7-e053-3a05fe0adea1 4
Targeted therapies: Friends or foes for patient's NK cell-mediated tumor immune-surveillance?, file e268c4cc-63b4-a6b7-e053-3a05fe0adea1 4
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias, file e268c4ca-2134-a6b7-e053-3a05fe0adea1 3
Isolation, Expansion, and Characterization of Natural Killer Cells and Their Precursors as a Tool to Study Cancer Immunosurveillance, file e268c4ca-3877-a6b7-e053-3a05fe0adea1 3
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment, file e268c4ca-69f8-a6b7-e053-3a05fe0adea1 3
HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia, file a9db5203-a8a1-4625-909e-d8f9ccaa84d9 2
Human NK cells: From surface receptors to clinical applications, file e268c4ca-2127-a6b7-e053-3a05fe0adea1 2
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells, file e268c4ca-3a51-a6b7-e053-3a05fe0adea1 2
HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition, file e268c4cb-4040-a6b7-e053-3a05fe0adea1 2
Interleukin-15 and cancer: Some solved and many unsolved questions, file e268c4cd-8d92-a6b7-e053-3a05fe0adea1 2
The roles of different forms of IL-15 in human melanoma progression, file da277884-7cc9-47d3-9beb-ab3d34bdc7a2 1
Identification of cytomegalovirus (CMV)-specific T lymphocytes displaying an effector-memory phenotype that kill CMV-infected target cells in an HLA-E-restricted fashion, file e268c4c5-ebcb-a6b7-e053-3a05fe0adea1 1
Titolo BOOK Chapter: NK cell effector mechanisms against solid tumors and leukemias and their exploitation in immunotherapy. Cancer Immunotherapy Principles and Practice, edited by Lisa H. Butterfield, PhD, Howard L. Kaufman, MD, FACS, and Francesco M. Marincola, MD, FACS, (Volume Editors)., file e268c4ca-1f55-a6b7-e053-3a05fe0adea1 1
Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines, file e268c4ca-5a07-a6b7-e053-3a05fe0adea1 1
Role of NK cells in immunotherapy and virotherapy of solid tumors, file e268c4ca-7634-a6b7-e053-3a05fe0adea1 1
Effect of tumor cells and tumor microenvironment on NK-cell function., file e268c4cb-6e76-a6b7-e053-3a05fe0adea1 1
Totale 1.339
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.275
article - articoli 3.271
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4
Totale 6.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020259 13 0 0 5 14 23 32 34 40 38 36 24
2020/2021314 21 18 16 32 16 27 34 22 24 32 38 34
2021/2022346 24 6 24 18 20 19 18 19 21 21 125 31
2022/2023316 6 19 81 44 17 78 10 9 25 10 14 3
2023/2024104 2 2 18 2 15 9 20 19 9 5 3 0
Totale 1.339